Combined presentation of severe pulmonary COVID-19 and multisystem inflammatory syndrome in children (MIS-C): two reported Egyptian pediatric cases

Abstract Background Initial reports from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic described children as being less susceptible to coronavirus disease (COVID-19) than adults. Later on, a severe and novel pediatric disorder termed multisystem inflammatory syndrome in c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tarek Hamed, Dina T. Sarhan
Formato: article
Lenguaje:EN
Publicado: SpringerOpen 2021
Materias:
Acceso en línea:https://doaj.org/article/1abd546a8af9482ba26d46028ed1c9d9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1abd546a8af9482ba26d46028ed1c9d9
record_format dspace
spelling oai:doaj.org-article:1abd546a8af9482ba26d46028ed1c9d92021-12-05T12:24:22ZCombined presentation of severe pulmonary COVID-19 and multisystem inflammatory syndrome in children (MIS-C): two reported Egyptian pediatric cases10.1186/s43054-021-00076-w2090-9942https://doaj.org/article/1abd546a8af9482ba26d46028ed1c9d92021-12-01T00:00:00Zhttps://doi.org/10.1186/s43054-021-00076-whttps://doaj.org/toc/2090-9942Abstract Background Initial reports from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic described children as being less susceptible to coronavirus disease (COVID-19) than adults. Later on, a severe and novel pediatric disorder termed multisystem inflammatory syndrome in children (MIS-C) emerged. Pediatric patients with SARS-CoV-2 are at risk for critical illness with severe pulmonary COVID-19 and MIS-C. Both are described as two distinct conditions, and the differentiation between them was the scope of many studies. In this report from Egypt, we will describe two unique pediatric cases presented by combined manifestations of severe pulmonary COVID-19 and MIS-C. Case presentation Two patients presented with severe pulmonary COVID-19 evident by pulmonary symptoms, signs, and advanced CO-RADS stage in lung CT were simultaneously fulfilling the clinical criteria of MIS-C including fever, multi-system affection, increased inflammatory markers in addition to the proved COVID-19 by positive serologic tests for SARS-CoV-2 but PCR was negative. Both patients responded well to immune-modulation therapy by IVIG and steroids and discharged well under closed follow-up. Conclusions Although it is debatable to present simultaneously, MIS-C should be considered in patients presenting with typical clinical findings and concerns for pulmonary COVID-19 once the criteria for MIS-C diagnosis is fulfilled. Starting treatment without delay can favor better prognosis.Tarek HamedDina T. SarhanSpringerOpenarticlePulmonaryCOVID-19MIS-CPediatricSARS-CoV-2EgyptPediatricsRJ1-570ENEgyptian Pediatric Association Gazette, Vol 69, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Pulmonary
COVID-19
MIS-C
Pediatric
SARS-CoV-2
Egypt
Pediatrics
RJ1-570
spellingShingle Pulmonary
COVID-19
MIS-C
Pediatric
SARS-CoV-2
Egypt
Pediatrics
RJ1-570
Tarek Hamed
Dina T. Sarhan
Combined presentation of severe pulmonary COVID-19 and multisystem inflammatory syndrome in children (MIS-C): two reported Egyptian pediatric cases
description Abstract Background Initial reports from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic described children as being less susceptible to coronavirus disease (COVID-19) than adults. Later on, a severe and novel pediatric disorder termed multisystem inflammatory syndrome in children (MIS-C) emerged. Pediatric patients with SARS-CoV-2 are at risk for critical illness with severe pulmonary COVID-19 and MIS-C. Both are described as two distinct conditions, and the differentiation between them was the scope of many studies. In this report from Egypt, we will describe two unique pediatric cases presented by combined manifestations of severe pulmonary COVID-19 and MIS-C. Case presentation Two patients presented with severe pulmonary COVID-19 evident by pulmonary symptoms, signs, and advanced CO-RADS stage in lung CT were simultaneously fulfilling the clinical criteria of MIS-C including fever, multi-system affection, increased inflammatory markers in addition to the proved COVID-19 by positive serologic tests for SARS-CoV-2 but PCR was negative. Both patients responded well to immune-modulation therapy by IVIG and steroids and discharged well under closed follow-up. Conclusions Although it is debatable to present simultaneously, MIS-C should be considered in patients presenting with typical clinical findings and concerns for pulmonary COVID-19 once the criteria for MIS-C diagnosis is fulfilled. Starting treatment without delay can favor better prognosis.
format article
author Tarek Hamed
Dina T. Sarhan
author_facet Tarek Hamed
Dina T. Sarhan
author_sort Tarek Hamed
title Combined presentation of severe pulmonary COVID-19 and multisystem inflammatory syndrome in children (MIS-C): two reported Egyptian pediatric cases
title_short Combined presentation of severe pulmonary COVID-19 and multisystem inflammatory syndrome in children (MIS-C): two reported Egyptian pediatric cases
title_full Combined presentation of severe pulmonary COVID-19 and multisystem inflammatory syndrome in children (MIS-C): two reported Egyptian pediatric cases
title_fullStr Combined presentation of severe pulmonary COVID-19 and multisystem inflammatory syndrome in children (MIS-C): two reported Egyptian pediatric cases
title_full_unstemmed Combined presentation of severe pulmonary COVID-19 and multisystem inflammatory syndrome in children (MIS-C): two reported Egyptian pediatric cases
title_sort combined presentation of severe pulmonary covid-19 and multisystem inflammatory syndrome in children (mis-c): two reported egyptian pediatric cases
publisher SpringerOpen
publishDate 2021
url https://doaj.org/article/1abd546a8af9482ba26d46028ed1c9d9
work_keys_str_mv AT tarekhamed combinedpresentationofseverepulmonarycovid19andmultisysteminflammatorysyndromeinchildrenmisctworeportedegyptianpediatriccases
AT dinatsarhan combinedpresentationofseverepulmonarycovid19andmultisysteminflammatorysyndromeinchildrenmisctworeportedegyptianpediatriccases
_version_ 1718371944755101696